RARECAUTIOUS

RARE Return on Equity (ROE) Analysis

718.8%

Higher than 95% of Healthcare sector peers

Updated 2556h ago·SEC filings & market data

Key Takeaway

RARE (RARE) has a Return on Equity (ROE) of 718.8% as of May 2026.

Sector Performance

95th percentile

RARE

718.8%

Sector Median

10.1%

Sector Avg

68.8%

📊

Deep Analysis

RARE (RARE) has a Return on Equity (ROE) of 718.8% as of May 2026.

This places RARE in the 95th percentile of the Healthcare sector, which has a median Return on Equity (ROE) of 10.1% and a sector average of 68.8%. RARE's Return on Equity (ROE) is 7016.8% above the sector median, a significant divergence that warrants closer examination. In context: ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.

Frequently Asked Questions

What does the Return on Equity (ROE) tell investors about RARE?

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.

How is the Return on Equity (ROE) calculated?

Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.

How does RARE's Return on Equity (ROE) compare to its sector?

RARE's Return on Equity (ROE) of 718.8% compares to a Healthcare sector median of 10.1%, placing it in the 95th percentile.

Who are RARE's closest peers by Return on Equity (ROE)?

The closest Healthcare peers by Return on Equity (ROE) include: ALGN (10.1%), TECH (9.0%), BIIB (7.7%), ABT (12.5%), TMO (13.5%).

📚

Learn More About Return on Equity (ROE)

What Is Return on Equity (ROE) and Is Higher Always Better?

Return on equity ROE measures how efficiently a company generates profit from shareholder capital. Learn how to decompose ROE using DuPont analysis and why high leverage can make it dangerous—with Apple and JPMorgan examples.

The Formula

Net Income / Shareholders' Equity

Why It Matters

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.